GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr20_+_10199468 Show fit | 30.51 |
ENST00000254976.2
ENST00000304886.2 |
synaptosomal-associated protein, 25kDa |
|
chr14_-_60097297 Show fit | 24.17 |
ENST00000395090.1
|
reticulon 1 |
|
chr1_-_204380919 Show fit | 23.56 |
ENST00000367188.4
|
protein phosphatase 1, regulatory subunit 15B |
|
chr8_+_11141925 Show fit | 15.05 |
ENST00000221086.3
|
myotubularin related protein 9 |
|
chr17_-_78450398 Show fit | 14.80 |
ENST00000306773.4
|
neuronal pentraxin I |
|
chr11_-_113746277 Show fit | 14.25 |
ENST00000003302.4
ENST00000545540.1 |
ubiquitin specific peptidase 28 |
|
chr3_+_115342159 Show fit | 13.93 |
ENST00000305124.6
|
growth associated protein 43 |
|
chr5_+_71403061 Show fit | 13.77 |
ENST00000512974.1
ENST00000296755.7 |
microtubule-associated protein 1B |
|
chr20_+_1246908 Show fit | 13.61 |
ENST00000381873.3
ENST00000381867.1 |
syntaphilin |
|
chr3_+_50712672 Show fit | 13.46 |
ENST00000266037.9
|
dedicator of cytokinesis 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 30.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
2.6 | 23.6 | GO:1903912 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 18.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.9 | 17.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 16.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.8 | 13.8 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
1.2 | 13.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.8 | 13.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 12.7 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
1.2 | 11.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 30.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.4 | 23.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 21.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.3 | 20.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 17.9 | GO:0000776 | kinetochore(GO:0000776) |
2.0 | 13.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.8 | 13.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 12.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 11.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.5 | 11.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 67.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 22.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 22.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 17.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
1.2 | 15.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
1.4 | 13.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.8 | 13.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
4.2 | 12.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.0 | 11.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.7 | 11.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 21.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 16.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 16.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 11.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 10.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 10.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 10.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 9.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 8.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 7.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 30.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 12.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 10.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 10.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 10.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 10.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 10.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 9.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 9.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 9.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |